Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001641172-25-025258·Chan Heng Fai Ambrose
Schedule 13D ownership disclosure
DSS INC
Common Stock, par value $0.02 per share · CUSIP: 26253C201
Event date: 2025-08-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Heng Fai Ambrose ChanReported CIK 0001261725
Shares: 6,730,059.00 · Class: 69.6%
- Alset Inc.Reported CIK 0001750106
Shares: 4,542,606.00 · Class: 47.0%
- Global Biomedical Pte. Ltd.
Shares: 311,634.00 · Class: 3.4%
- Alset International LimitedReported CIK 0001660984
Shares: 1,379,943.00 · Class: 15.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-025258
- Form type
- SCHEDULE 13D/A
- Filer
- Chan Heng Fai Ambrose
- CIK
- CIK 1261725
- Filed
- Aug 22, 2025
- Reporting period
- Aug 20, 2025
- Description
- Schedule 13D beneficial ownership